Increased risk of colorectal cancer among patients with biliary tract inflammation: A 5-year follow-up study

International Journal of Cancer

Volumn 128, Issue 2, 2011, Pages 447-452

  Lin, Hsiu Li ^a,b   Lin, Hsiu Chen ^b   Lin, Ching Chun ^b   Lin, Herng Ching ^b  

^a General Cathay Hospital   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

biliary tract inflammation; colorectal cancer; epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; BILIARY TRACT INFLAMMATION; CANCER RISK; CHOLECYSTITIS; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; CHOLANGITIS; CHOLECYSTITIS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 78649581203     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25354     Document Type: Article

References (35)

1. Lee CC, Chang IJ, Lai YC, Chen SY, Chen SC,. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol 2007; 102: 563-9.
2. Gupta E, Chakravarti A,. Viral infections of the biliary tract. Saudi J Gastroenterol 2008; 14: 158-60.
3. Bornman PC, van Beljon JI, Krige JE,. Management of cholangitis. J Hepatobil Pancreat Surg 2003; 10: 406-14.
4. What if it's acute cholangitis? Drug Ther Bull 2005; 43: 62-4.
5. Bektaş M, Dökmeci A, Cinar K, Halici I, Oztas E, Karayalcin S, Idilman R, Sarioglu M, Ustun Y, Nazligul Y, Ormeci N, Ozkan H, et al. Endoscopic management of biliary parasitic diseases. Dig Dis Sci 2009. In press.
6. Hanau LH, Steigbigel NH,. Acute (ascending) cholangitis. Infect Dis Clin North Am 2000; 14: 521-46.
7. Stewart L, Griffiss JM, Way LW,. Spectrum of gallstone disease in the veterans population. Am J Surg 2005; 190: 746-51.
8. Podnos YD, Jimenez JC, Wilson SE,. Intra-abdominal sepsis in elderly persons. Clin Infect Dis 2002; 35: 62-8.
9. Siegman-Igra Y, Schwartz D, Konforti N, Perluk C, Rozin RR,. Septicemia from biliary tract infection. Arch Surg 1988; 123: 366-8.
10. Sugiyama M, Atomi Y,. Treatment of acute cholangitis due to choledocholithiasis in elderly and younger patients. Arch Surg 1997; 132: 1129-33.
11. Kuo CH, Changchien CS, Chen JJ, Tai DI, Chiou SS, Lee CM,. Septic acute cholecystitis. Scand J Gastroenterol 1995; 30: 272-5.
12. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics. CA Cancer J Clin 2008; 58: 71-96.
14. Meissner HI, Breen N, Klabunde CN, Vernon SW,. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomark Prev 2006; 15: 389-94.
15. Taiwan Department of Health. Health statistics in Taiwan 2008. Taipei, Taiwan: Taiwan Department of Health, 2009.
16. Wu AH, Pearce CL, Tseng CC, Templeman C, Pike MC,. Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer 2009; 124: 1409-15.
17. Vairaktaris E, Serefoglou Z, Avgoustidis D, Yapijakis C, Critselis E, Vylliotis A, Spyridonidou S, Derka S, Vassiliou S, Nkenke E, Patsouris E,. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 2009; 45: 247-53.
18. Vasto S, Carruba G, Lio D, Colonna-Romano G, Di Bona D, Candore G, Caruso C,. Inflammation, ageing and cancer. Mech Ageing Dev 2009; 130: 40-5.
19. Slattery ML, Wolff RK, Herrick J, Caan BJ, Samowitz W,. Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer 2009; 125: 1698-704.
20. Itzkowitz SH, Yio X,. Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-G17.
21. Triantafillidis JK, Nasioulas G, Kosmidis PA,. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009; 29: 2727-37.
22. Ochsenkühn T, Bayerdörffer E, Meining A, Schinkel M, Thiede C, Nüssler V, Sackmann M, Hatz R, Neubauer A, Paumgartner G,. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 1999; 85: 1664-9.
23. Broome U, Bergquist A,. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006; 26: 31-41.
24. Friedman GD, Goldhaber MK, Quesenberry CP, Jr,. Cholecystectomy and large bowel cancer. Lancet 1987; 1: 906-8.
25. Adami HO, Meirik O, Gustavsson S, Nyrén O, Krusemo UB,. Colorectal cancer after cholecystectomy: absence of risk increase within 11-14 years. Gastroenterology 1983; 85: 859-65.
26. van Faassen A, Ochsenkühn T, Houterman S, van der Ploeg EM, Bueno-de-Mesquita BH, Ocké MC, Bayerdörffer E, Janknegt RA,. Plasma deoxycholic acid is related to deoxycholic acid in faecal water. Cancer Lett 1997; 114: 293-4.
27. Bernstein H, Bernstein C, Payne CM, Dvorak K,. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 2009; 15: 3329-40.
28. Pearson JR, Gill CI, Rowland IR,. Diet, fecal water, and colon cancer-development of a biomarker. Nutr Rev 2009; 67: 509-26.
29. American Cancer Society. Cancer facts and figures. American Cancer Society, 2005.
30. Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ,. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci USA 2008; 105: 652-6.
31. McKay CJ, Glen P, McMillan DC,. Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol 2008; 22: 65-73.
32. Michaud DS,. Chronic inflammation and bladder cancer. Urol Oncol 2007; 25: 260-8.
33. Roxburgh CS, Crozier JE, Maxwell F, Foulis AK, Brown J, McKee RF, Anderson JH, Horgan PG, McMillan DC,. Comparison of tumour-based (Petersen index) and inflammation-based (Glasgow prognostic score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer 2009; 100: 701-6.
34. Breynaert C, Vermeire S, Rutgeerts P, Van Assche G,. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Acta Gastroenterol Belg 2008; 71: 367-72.
35. Thomsen RW, Thomsen HF, Nørgaard M, Cetin K, McLaughlin JK, Tarone RE, Fryzek JP, Sørensen HT,. Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark. Cancer 2008; 113: 3410-9.